ETCTN 10366: A phase 1 study of DNA-PK inhibitor peposertib in combination with hypofractionated radiotherapy for the treatment of locally advanced pancreatic adenocarcinoma

被引：0
|
作者：
Davis, S. Lindsey
Kasi, Anup
Dayyani, Farshid
Ocean, Allyson J.
Chung, Vincent
Al Hallak, Mohammed Najeeb
Fountzilas, Christos
Hu, Junxiao
Murray, Judy
Allegra, Carmen
Gore, Steven
Beumer, Jan Hendrik
Goodman, Karyn A.
机构：
[1] Univ Colorado, Canc Ctr, Aurora, CO USA
[2] Univ Kansas, Canc Ctr, Westwood, KS USA
[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA
[4] NewYork Presbyterian Weill Cornell Med Ctr, New York, NY USA
[5] City Hope Comprehens Canc Ctr, Duarte, CA USA
[6] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[7] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[8] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[9] NCI, Bethesda, MD 20892 USA
[10] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[11] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4168
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
    Nuriye Ozdemir
    Huseyin Abali
    Murat Vural
    Suayib Yalcin
    Berna Oksuzoglu
    Burak Civelek
    Dilek Oguz
    Birol Bostanci
    Bulent Yalcin
    Nurullah Zengin
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1139 - 1147
  • [42] Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study
    Ozdemir, Nuriye
    Abali, Huseyin
    Vural, Murat
    Yalcin, Suayib
    Oksuzoglu, Berna
    Civelek, Burak
    Oguz, Dilek
    Bostanci, Birol
    Yalcin, Bulent
    Zengin, Nurullah
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1139 - 1147
  • [43] Hypofractionated radiotherapy for patients with locally advanced pancreatic cancer using tomotherapy Hi-Art and CyberKnife: A study of the treatment outcome and failure patterns.
    Jang, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [44] Phase I study of irinotecan and cisplatin in combination with pelvic radiotherapy in the treatment of locally advanced cervical cancer: A GINECO trial
    Fabbro, M.
    Gladieff, L.
    Guichard, F.
    El Demery, M.
    Dalenc, F.
    Kerr, C.
    Delannes, M.
    Paraiso, D.
    Pujade-Lauraine, E.
    Kurtz, J. -E.
    GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 276 - 280
  • [45] A phase Ib/IIa study of combination therapy with gemcitabine and Atu027 in patients with locally advanced or metastatic pancreatic adenocarcinoma.
    Schultheis, Beate
    Strumberg, Dirk
    Kuhlmann, Jan
    Wolf, Martin
    Link, Karin
    Seufferlein, Thomas
    Kaufmann, Joerg
    Gebhardt, Frank
    Bruyniks, Nico
    Pelzer, Uwe
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [46] A phase Ib dose escalation, safety, and tolerability study of sonidegib in combination with gemcitabine in patients with locally advanced or metastatic pancreatic adenocarcinoma.
    Macarulla, Teresa
    Tabernero, Josep
    Palmer, Daniel H.
    Sharma, Sunil
    Yu, Kenneth H.
    Sellami, Dalila B.
    Zhou, Jocelyn
    Yi, Wu
    Boss, Hildegard
    Kwak, Eunice L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [47] Phase I/ II Study of Concurrent Chemoradiotherapy With Gemcitabine and S-1 for Unresectable Locally Advanced Pancreatic Adenocarcinoma
    Ioka, T.
    Arimoto, N.
    Ashida, R.
    Takakura, R.
    Nakamura, S.
    Nishiyama, K.
    Tanaka, S.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S451 - S451
  • [48] A PHASE II STUDY OF RETIFANLIMAB (PD-1 INHIBITOR) IN COMBINATION WITH BEVACIZUMAB AND HYPOFRACTIONATED RADIOTHERAPY FOR RECURRENT GLIOBLASTOMA: NCT03532295
    Butt, Omar
    Huang, Jiayi
    Luo, Jingqin
    Tao, Yu
    Strowd, Roy
    Hissim, Deanna
    Kizilbash, Sani
    Abraham, Christopher
    Anstass, George
    Johanns, Tanner
    Kim, Albert
    Ciorba, Matthew
    Chheda, Milan G.
    Campian, Jian
    NEURO-ONCOLOGY, 2022, 24 : 61 - 61
  • [49] Phase I study of S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic carcinoma.
    Sudo, K
    Yamaguchi, T
    Ito, H
    Ishihara, T
    Nakamura, K
    Kawakami, H
    Uno, T
    Saisho, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 354S - 354S
  • [50] PHASE II STUDY OF ORAL S-1 AND CONCURRENT RADIOTHERAPY IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
    Sudo, Kentaro
    Yamaguchi, Taketo
    Ishihara, Takeshi
    Nakamura, Kazuyoshi
    Hara, Taro
    Denda, Tadamichi
    Tawada, Katsunobu
    Imagumbai, Toshiyuki
    Araki, Hitoshi
    Sakai, Mitsuhirc
    Hatano, Kazuo
    Kawakami, Hiroyuki
    Uno, Takashi
    Ito, Hisao
    Yokosuka, Osamu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (01): : 119 - 125
12345